# Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

> **NCT00206583** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 499 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** EV/DNG (Qlaira, BAY86-5027, SH T00658ID)

## Key facts

- **NCT ID:** NCT00206583
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-06
- **Final completion:** 2007-07
- **Target enrollment:** 499 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206583, "Efficacy and Safety Study of an Oral Contraceptive in Healthy Females". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00206583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*